IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC Felip, E., Vallieres, E., Zhou, C., Wakelee, H., Bondarenko, I., Sakai, H., Saito, H., Ursol, G., Kawaguchi, K., Liu, Y., Levchenko, E., Kislov, N., Reck, M., Liersch, R., McNally, V. A., Zhu, Q., Ding, B., Bennett, E., Gitlitz, B., Altorki, N. K. ELSEVIER. 2021: S1319

View details for DOI 10.1016/j.annonc.2021.08.2120

View details for Web of Science ID 000700527703519